Evaluation of two concentration methods for detecting Giardia and Cryptosporidium in water

The cartridge filtration method and membrane filtration method based on the fluorescent antibody procedure were evaluated for their recovery efficiencies and detection limits of Giardia and Cryptosporidium. We assessed the performances of the two concentration methods for water samples collected from Taiwan water treatment plants. The membrane filtration method was characterized by higher recovery rate and detection limit comparing with the cartridge filtration method. The occurrences of both parasites, and the relationships of parasite concentrations with indicator microorganisms show inconsistency between the two methods. It was discovered that water turbidity reduced the recovery efficiencies, and raised the detection limits for both parasites regardless of the method used.     

Nitrification efficiency and nitrifying bacteria abundance in combined AS-RBC and A2O systems

This study makes a comparison between the nitrification performance of TNCU-I (a combined activated sludge-rotating biological contactor process) and A2O systems by the use of a pilot plant and batch experiments. The nitrifier abundance in both systems was determined, using cloning-denaturing gradient gel electrophoresis (DGGE) and fluorescent in-situ hybridization (FISH), to investigate the role of rotating biological contactor in the TNCU-I process. The stability of the nitrification performance and the specific nitrification rate were found to be greater in TNCU-I system than in the A2O system. RBC biofilm promoted nitrifying activity that contributed to the nitrification performance, especially at a low SRT. By using the cloning-DGGE method, the genera Nitrosospira and Nitrospira were found to be present in all the samples, while the genus Nitrosomonas was observed only in the TNCU-I RBC biofilm. In addition, the proportions of ammonia oxidizer in the TNCU-I RBC biofilm, the TNCU-I activated sludge and the A2O activated sludge were 11.4%, 13.2%, and 4.1%, respectively, higher than the nitrite oxidizer fractions of 3.3%, 5.7% and 2.1%, respectively, according to the cloning-DGGE method. On the other hand, the proportions of ammonia oxidizers in the afore-mention materials were 10.3%, 13.7%, and 5.2%, higher than the nitrite oxidizer fractions of 2.5%, 3.6% and 2.3%, according to the FISH experiments. This implies that the proportion of ammonia oxidizer in the TNCU-I process was 3.2 and 2.6 times that in the A2O process, determined by the cloning-DGGE and FISH methods, respectively. These amounts are also close to the ammonia oxidization rate of 2.9 times. All the data show that RBC added to the aerobic zone of TNCU-I process would increase the nitrifier abundance and enhance the nitrification performance of the system.     

Cu-Zn-Al合金马氏体稳定化与母相有序态SCIEI

采用X射线衍射和内耗测量研究了Cu-Zn-Al合金不同热处理条件对马氏体相变和母相有序态的影响。研究表明,“淬火-时效”试样从室温加热到320℃马氏体完全消失为止始终未发生逆相变。分级淬火短期等温试样出现B2?9R和DO_3?18R两种马氏体相变共存。随着等温时间的增长,B2?9R相变消失,与此同时DO_3?18R相变增强。然而,淬火后立即上淬到100—150℃等温的试样只出现B2?9R相变,即使等温时间增长也能继续保持。显然,从高温快冷不能抑制A2?B2有序,却可以抑制B2?DO_3有序。虽然分级和上淬处理时母相所处的湿度相同,但其有序态却各异,足够的空位浓度是发生B2?DO_3有序转变的必要条件。文中讨论了Cu-Zn-Al合金马氏体稳定化的可能机制。     

Ceramic wear maps

Ceramic wear maps have been developed to elucidate the complex interactions of the operating parameters, environments, and wear mechanisms. This paper summarizes these interactions for four ceramics, alumina, yttria-doped zirconia, silicon carbide and silicon nitride. Wear maps of these ceramics are systematically constructed using measured data under dry sliding, water, and paraffin lubricated conditions. For each material, different wear level regions acid wear transition zones are identified as a function of operating conditions and lubrication conditions. Wear mechanism studies performed within each wear region give rise to the wear mechanism maps. These maps facilitate material comparison and selection. The knowledge of wear, wear transitions, and wear mechanisms for a material pair enables realistic wear model development. One outcome of this approach is the recognition that a single wear model for a material pair cannot cover all operating conditions and environments.

As wear maps are constructed today, they are material pair specific. Within a material pair, there are microstructural dependence and surface properties influence. These parameters can change substantially for a given chemical composition of the material. How to incorporate these factors into the wear map research remains an issue. The search for a universal parameter such as the “asperity temperature” in Ashby's wear map continues in spite of mounting evidence that this may not be practical or feasible. But the hope remains that some parameters can be identified to normalize a large number of materials, operating conditions, and environments for tribological applications. Systematic wear maps are the first steps in this direction.     

Technical Summary of the First U.S. Plasma Jet Workshop

This paper provides a technical summary of the first U.S. Plasma Jet Workshop, which was sponsored by the DOE Office of Fusion Energy Sciences and held at Los Alamos National Laboratory on January 24–25, 2008. The purpose of the workshop was to bring together members of the national plasma jet research community in order to discuss ongoing research and identify research needs and opportunities in plasma jets and their applications, which include fundamental studies of high energy density (HED) plasmas, magneto-inertial fusion (MIF), laboratory astrophysics, and disruption mitigation and fueling for magnetic confinement devices. Over the course of the workshop, about equal time was devoted to short technical talks and group discussions.     

Transcriptomic Analysis Suggests Auxin Regulation in Dorsal-Ventral Petal Asymmetry of Wild Progenitor Sinningia speciosa

The establishment of dorsal–ventral (DV) petal asymmetry is accompanied by differential growth of DV petal size, shape, and color differences, which enhance ornamental values. Genes involved in flower symmetry in Sinningia speciosa have been identified as CYCLOIDEA (SsCYC), but which gene regulatory network (GRN) is associated with SsCYC to establish DV petal asymmetry is still unknown. To uncover the GRN of DV petal asymmetry, we identified 630 DV differentially expressed genes (DV-DEGs) from the RNA-Seq of dorsal and ventral petals in the wild progenitor, S. speciosa ‘ES’. Validated by qRT-PCR, genes in the auxin signaling transduction pathway, SsCYC, and a major regulator of anthocyanin biosynthesis were upregulated in dorsal petals. These genes correlated with a higher endogenous auxin level in dorsal petals, with longer tube length growth through cell expansion and a purple dorsal color. Over-expression of SsCYC in Nicotiana reduced petal size by regulating cell growth, suggesting that SsCYC also controls cell expansion. This suggests that auxin and SsCYC both regulate DV petal asymmetry. Transiently over-expressed SsCYC, however, could not activate most major auxin signaling genes, suggesting that SsCYC may not trigger auxin regulation. Whether auxin can activate SsCYC or whether they act independently to regulate DV petal asymmetry remains to be explored in the future.     

Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice

HLJ1 (also called DNAJB4) is a member of the DNAJ/Hsp40 family and plays an important role in regulating protein folding and activity. However, there is little information about the role of HLJ1 in the regulation of physiological function. In this study, we investigated the role of HLJ1 in blood coagulation using wild-type C57BL/6 mice and HLJ1-null (HLJ1^-/-) mice. Western blot analysis and immunohistochemistry were used to assess the expression and distribution of HLJ1 protein, respectively. The tail bleeding assay was applied to assess the bleeding time and blood loss. A coagulation test was used for measuring the activity of extrinsic, intrinsic and common coagulation pathways. Thromboelastography was used to measure the coagulation parameters in the progression of blood clot formation. The results showed that HLJ1 was detectable in plasma and bone marrow. The distribution of HLJ1 was co-localized with CD41, the marker of platelets and megakaryocytes. However, genetic deletion of HLJ1 did not alter blood loss and the activity of extrinsic and intrinsic coagulation pathways, as well as blood clot formation, compared to wild-type mice. Collectively, these findings suggest that, although HLJ1 appears in megakaryocytes and platelets, it may not play a role in the function of blood coagulation under normal physiological conditions.     

A wavelet transform based POCS Superresolution algorithm

Research interest in multi-frame Superresolution has risen substantially in recent years.This paper presents a modified Projection Onto Convex Set (POCS) superresolution method based on wavelet transform.The method analyzes the image formation model from wavelet multiresolution analysis point of view and defines an closed convex set and its corresponding projection based on wavelet transform.An iterative procedure is utilized to reduce the estimated errors of the result image,and this guarantees the estimated image to lay in the intersection of different convex sets,thus produces a high resolution image with a reduced error.The effectiveness of the algorithm is demonstrated by experimental results.     

Pathogenesis and Treatment of Myeloma-Related Bone Disease

Multiple myeloma is a hematologic malignancy of plasma cells that causes bone-destructive lesions and associated skeletal-related events (SREs). The pathogenesis of myeloma-related bone disease (MBD) is the imbalance of the bone-remodeling process, which results from osteoclast activation, osteoblast suppression, and the immunosuppressed bone marrow microenvironment. Many important signaling cascades, including the RANKL/RANK/OPG axis, Notch signaling, the Wnt/β-Catenin signaling pathways, and signaling molecules, such as DKK-1, sclerostin, osteopontin, activin A, chemokines, and interleukins are involved and play critical roles in MBD. Currently, bisphosphonate and denosumab are the gold standard for MBD prevention and treatment. As the molecular mechanisms of MBD become increasingly well understood, novel agents are being thoroughly explored in both preclinical and clinical settings. Herein, we will provide an updated overview of the pathogenesis of MBD, summarize the clinical management and guidelines, and discuss novel bone-modifying therapies for further management of MBD.